CDK4/6 Inhibitor Shows Promise for Metastatic Breast Cancer

Palbociclib plus letrozole extend Progression-free survival for women with metastatic hormone Receptor-positive breast cancer

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.